Rocket Pharmaceuticals Valuation
| RCKT Stock | USD 3.04 0.30 8.98% |
At this time, the company appears to be undervalued. Rocket Pharmaceuticals holds a recent Real Value of $12.65 per share. The prevailing price of the company is $3.04. Our model determines the value of Rocket Pharmaceuticals from analyzing the company fundamentals such as Shares Outstanding of 107.74 M, return on equity of -0.6, and Shares Owned By Institutions of 93.44 % as well as examining its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Rocket Pharmaceuticals' price fluctuation is moderately volatile at this time. Calculation of the real value of Rocket Pharmaceuticals is based on 3 months time horizon. Increasing Rocket Pharmaceuticals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Rocket Pharmaceuticals' intrinsic value may or may not be the same as its current market price of 3.04, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.04 | Real 12.65 | Hype 2.94 | Naive 2.66 |
The intrinsic value of Rocket Pharmaceuticals' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Rocket Pharmaceuticals' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Rocket Pharmaceuticals helps investors to forecast how Rocket stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Rocket Pharmaceuticals more accurately as focusing exclusively on Rocket Pharmaceuticals' fundamentals will not take into account other important factors: Rocket Pharmaceuticals Total Value Analysis
Rocket Pharmaceuticals is at this time forecasted to have valuation of 1.69 B with market capitalization of 327.52 M, debt of 25.5 M, and cash on hands of 321.37 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Rocket Pharmaceuticals fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.69 B | 327.52 M | 25.5 M | 321.37 M |
Rocket Pharmaceuticals Asset Utilization
One of the ways to look at asset utilization of Rocket is to check how much profit was generated for every dollar of assets it reports. Rocket Pharmaceuticals holds a negative application of assets of -0.35 pct., losing $0.00348 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Rocket Pharmaceuticals shows how discouraging it operates for each dollar spent on its assets.Rocket Pharmaceuticals Ownership Allocation
Rocket Pharmaceuticals owns a total of 107.74 Million outstanding shares. The majority of Rocket Pharmaceuticals outstanding shares are owned by third-party entities. These institutional holders are usually referred to as non-private investors looking to secure positions in Rocket Pharmaceuticals to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Rocket Pharmaceuticals. Please pay attention to any change in the institutional holdings of Rocket Pharmaceuticals as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Rocket Pharmaceuticals Profitability Analysis
Net Loss for the year was (258.75 M) with profit before overhead, payroll, taxes, and interest of 0.About Rocket Pharmaceuticals Valuation
The stock valuation mechanism determines Rocket Pharmaceuticals' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Rocket Pharmaceuticals based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Rocket Pharmaceuticals. We calculate exposure to Rocket Pharmaceuticals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Rocket Pharmaceuticals's related companies.Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. Rocket Pharmaceuticals, Inc. is headquartered in Cranbury, New Jersey. Rocket Pharmaceuticals operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 151 people.
Rocket Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Rocket Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 94.8 M |
Additional Tools for Rocket Stock Analysis
When running Rocket Pharmaceuticals' price analysis, check to measure Rocket Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rocket Pharmaceuticals is operating at the current time. Most of Rocket Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Rocket Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rocket Pharmaceuticals' price. Additionally, you may evaluate how the addition of Rocket Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.